Why Childhood Cancer

15,700 children in the U.S. are diagnosed with cancer each year, and 1 in 5 of those will not survive. Thankfully, we know that funding research can significantly impact survival rates and save lives. But we still have work to do to ensure that every child diagnosed with cancer can live a happy and healthy life. Here are some key reasons why we’re riding together this September to fight kids’ cancer.

  1. About 1 in 285 children will develop cancer before the age of 20.
  2. Cancer remains the most common cause of death by disease among children in the United States.
  3. More than 95% of childhood cancer survivors will have a significant health issue related to their cancer or treatment by the time they are 45 years old.

All funds raised support Children’s Cancer Research Fund, a national leader in childhood cancer research fueling scientific discoveries for safer, more effective treatments and cures for kids living with cancer. We also provide resources and programs that help kids and families as they navigate the difficult experience of cancer treatment and survivorship. Your support allows us to continue our work to fight kids’ cancer and give kids the brighter futures they deserve. 

The road to better treatment options and cures always starts with riders like you. 

When you ride for Great Cycle Challenge, you are supporting the brightest minds whose ideas are making the greatest impact for kids.

We fund research at institutions nationwide, focusing on peer-reviewed projects that allow researchers to prove their idea, then reach for even larger grants.  More than half of all pediatric cancer research funding comes from organizations like Children’s Cancer Research Fund through supporters like you. With your help, we can continue to move childhood cancer research forward. .

We want to ensure your fundraising efforts have the greatest impact, so we focus our investments in three main areas: hard-to-treat diseases, survivorship research and health disparities. Read more about our unique approach to funding research.